A. Pereira

发表

Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort

I. Benseñor, P. Lotufo, J. Krieger, 2022, Atherosclerosis plus.

Screening of ABCG5 and ABCG8 Genes for Sitosterolemia in a Familial Hypercholesterolemia Cascade Screening Program

J. Krieger, M. Miname, V. Z. Rocha, 2022, Circulation. Genomic and precision medicine.

Effect of Occurrence of Lamin A/C (LMNA) Genetic Variants in a Cohort of 101 Consecutive Apparent “Lone AF” Patients: Results and Insights

J. Krieger, M. Scanavacca, A. Pedrosa, 2022, Frontiers in Cardiovascular Medicine.

Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.

J. Krieger, R. Pedrosa, C. Mady, 2013, American heart journal.

KRAS gene mutations in Noonan syndrome familial cases cluster in the vicinity of the switch II region of the G‐domain: Report of another family with metopic craniosynostosis

J. Krieger, A. Pereira, C. Kim, 2012, American journal of medical genetics. Part A.

Extensive xanthomas and severe subclinical atherosclerosis in homozygous familial hypercholesterolemia.

E. Ribeiro, R. Santos, M. Miname, 2013, Journal of the American College of Cardiology.

CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy

J. Krieger, A. Pereira, J. Issa, 2015, European Journal of Clinical Pharmacology.

Recurrence of frontometaphyseal dysplasia in two sisters with a mutation in FLNA and an atypical paternal phenotype: Insights into genotype–phenotype correlation

S. Robertson, M. Passos-Bueno, C. Kim, 2015, American journal of medical genetics. Part A.

Hemochromatosis Gene Variants in Three Different Ethnic Populations: Effects of Admixture for Screening Programs

J. Krieger, A. Pereira, G. A. Mota, 2001, Human biology.

Are Noonan syndrome and Noonan-like/multiple giant cell lesion syndrome distinct entities?

J. Krieger, C. Kim, D. Bertola, 2001, American journal of medical genetics.

Metabolic syndrome alters relationships between cardiometabolic variables, cognition and white matter hyperintensity load

A. Sterr, J. Krieger, A. Sterr, 2019, Scientific Reports.

Pharmacological treatment with lipid-lowering agents after molecular identification of familial hypercholesterolemia: results from the Hipercol Brasil cohort.

R. Santos, T. G. Oliveira, A. Pereira, 2022, Journal of clinical lipidology.

Screening for Familial Hypercholesterolemia in Small Towns: Experience from 11 Brazilian Cities at the HipercolBrasil Program

J. Krieger, A. Pereira, R. Santos, 2020 .

Hemochromatosis gene variants in patients with cardiomyopathy.

A. Mansur, J. Krieger, E. Bocchi, 2001, The American journal of cardiology.

CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation

I. Benseñor, P. Lotufo, J. Krieger, 2012, European Journal of Clinical Pharmacology.

Frequency of 22q11.2 microdeletion in sporadic non-syndromic tetralogy of Fallot cases.

J. Krieger, A. Lopes, S. Mesquita, 2008, International journal of cardiology.